Daily or weekly use of paracetamol linked to asthmaMarch 17, 2000The use of aspirin and paracetamol was compared in 664 asthmatics and 910 people without asthma over a period of 12 months. The study participants were aged between 16 and 49, and drawn from 40 general practices in South London. Information on potential risk factors for asthma, such a smoking and indicators of family income, was also obtained. People who took paracetamol every week were almost 80 per cent more likely to have asthma than those who never took the analgesic. And those who took paracetamol every day were over twice as likely to have asthma. Frequent use of paracetamol was also associated with more severe asthma, and with rhinitis in those who did not have asthma. These findings did not apply to the use of aspirin, and remained true even after adjusting for other potential risk factors. Very few asthmatics were taking paracetamol frequently for asthma symptoms, and avoidance of aspirin did not seem to explain the findings. The authors suggest that frequent use of paracetamol decreases circulating levels of the antioxidant glutathione, high levels of which are found in the lining of the airways and the nose. Glutathione is thought to protect the lungs from the harmful effects of pollutants and free radicals, numbers of which are high in the lungs of asthmatics, because of the inflammatory nature of the disease. The authors caution that asthmatics should not substitute aspirin or NSAIDS for paracetamol on the basis of these findings, as this could be dangerous. Rather, they advise frequent users of paracetamol to cut down on their intake, if possible. Aspirin should not be given to children, regardless of whether they have asthma, say the authors, because of the risk of Reye?s syndrome, a rare but potentially fatal condition which usually follows a viral infection. AlphaGalileo Foundation |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Exposures to metals and diesel emissions in air linked to respiratory symptoms in children Exposure shortly after birth to ambient metals from residential heating oil combustion and particles from diesel emissions are associated with respiratory symptoms in young inner city children. Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later New research presents strong evidence that the "synergistic" effect of early-life exposure to both outdoor traffic-related pollution and indoor endotoxin causes more harm to developing lungs than one or the other exposure alone. Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||